Relative Bioavailability, Transdermally Administered EE and GSD, 3 Applications Sites
Clinical trial NCT01083264 · COMPLETED
Trial details
- NCT number
- NCT01083264
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.